Astragalus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

Effects of PG2 on Fatigue-Related Symptom Clusters
Condition:   Cancer-related FatigueInterventions:   Drug: Astragalus Polysaccharides 500 mg;   Drug: Astragalus Polysaccharides 250 mgSponsor:   Taipei Medical UniversityRecruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2016 Category: Research Source Type: clinical trials

Effects of PG2 on Fatigue-Related Symptom Clusters
Condition:   Cancer-related FatigueInterventions:   Drug: Astragalus Polysaccharides 500 mg;   Drug: Astragalus Polysaccharides 250 mgSponsor:   Taipei Medical UniversityNot yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2016 Category: Research Source Type: clinical trials

Effects of PG2 on Fatigue-Related Symptom Clusters
Condition:   Cancer-related FatigueInterventions:   Drug: Astragalus Polysaccharides 500 mg;   Drug: Astragalus Polysaccharides 250 mgSponsor:   Taipei Medical UniversityRecruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2016 Category: Research Source Type: clinical trials

The Organ Protection of Astragalus in Subjects With Metabolic Syndrome
Condition:   Metabolic SyndromeInterventions:   Drug: low dose Astragalus;   Drug: high dose astagalusSponsors:   LanZhou University;   LanZhou UniversityRecruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2013 Category: Research Source Type: clinical trials